AU2002233220A1 - Medicament for preventing or treating tumors caused by human papilloma virus type 18 - Google Patents
Medicament for preventing or treating tumors caused by human papilloma virus type 18Info
- Publication number
- AU2002233220A1 AU2002233220A1 AU2002233220A AU3322002A AU2002233220A1 AU 2002233220 A1 AU2002233220 A1 AU 2002233220A1 AU 2002233220 A AU2002233220 A AU 2002233220A AU 3322002 A AU3322002 A AU 3322002A AU 2002233220 A1 AU2002233220 A1 AU 2002233220A1
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- preventing
- virus type
- papilloma virus
- human papilloma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10059630.4 | 2000-12-01 | ||
DE2000159630 DE10059630A1 (en) | 2000-12-01 | 2000-12-01 | Medicines to prevent or treat tumor caused by human papillomavirus type 18 |
PCT/EP2001/014038 WO2002043757A2 (en) | 2000-12-01 | 2001-11-30 | Medicament for preventing or treating tumors caused by human papilloma virus type 18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002233220A1 true AU2002233220A1 (en) | 2002-06-11 |
Family
ID=7665349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002233220A Abandoned AU2002233220A1 (en) | 2000-12-01 | 2001-11-30 | Medicament for preventing or treating tumors caused by human papilloma virus type 18 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040101533A1 (en) |
AU (1) | AU2002233220A1 (en) |
DE (1) | DE10059630A1 (en) |
WO (1) | WO2002043757A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4474264B2 (en) | 2004-08-20 | 2010-06-02 | 生寶生物科技股▲ふん▼有限公司 | Fusion protein of cervical cancer suppression |
WO2006063065A2 (en) | 2004-12-08 | 2006-06-15 | Gen-Probe Incorporated | Detection of nucleic acids from multiple types of human papillomaviruses |
CN101570571B (en) | 2007-04-29 | 2012-07-11 | 北京万泰生物药业股份有限公司 | Truncated human papilloma virus 18 type L1 protein |
US9428555B2 (en) | 2007-04-29 | 2016-08-30 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | Truncated L1 protein of Human Papillomavirus type 16 |
WO2011109415A2 (en) * | 2010-03-02 | 2011-09-09 | Amgen Inc. | Reducing viscosity of pharmaceutical formulations |
JP2013521000A (en) * | 2010-03-04 | 2013-06-10 | パーデュー・リサーチ・ファウンデーション | Integrated test method combining flow cytometry and multiple HPV genotyping |
US9737250B2 (en) * | 2013-03-15 | 2017-08-22 | Dexcom, Inc. | Membrane for continuous analyte sensors |
KR101680567B1 (en) | 2014-07-09 | 2016-11-29 | 연세대학교 산학협력단 | Use of HPV peptide for diagnostic and treatment of cervical cancer |
WO2016006873A1 (en) * | 2014-07-09 | 2016-01-14 | 연세대학교 산학협력단 | Use of human papillomavirus peptide for diagnosis and treatment of cervical cancer |
WO2021013063A1 (en) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | Chimeric human papillomavirus type 16 l1 protein |
US20230087422A1 (en) * | 2020-02-07 | 2023-03-23 | Isa Pharmaceuticals B.V. | Treatment of hpv-related diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004687A (en) * | 1985-05-21 | 1991-04-02 | University Of Georgia Research Foundation, Inc. | Insect virus vector with broadened host range |
US5820870A (en) * | 1995-03-22 | 1998-10-13 | Merck & Co., Inc. | Recombinant human papillomavirus type 18 vaccine |
US6228368B1 (en) * | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
DE19812941A1 (en) * | 1998-03-24 | 1999-10-07 | Medigene Ag | Medicines to prevent or treat papilloma virus-specific tumor |
-
2000
- 2000-12-01 DE DE2000159630 patent/DE10059630A1/en not_active Withdrawn
-
2001
- 2001-11-30 AU AU2002233220A patent/AU2002233220A1/en not_active Abandoned
- 2001-11-30 WO PCT/EP2001/014038 patent/WO2002043757A2/en not_active Application Discontinuation
- 2001-11-30 US US10/433,091 patent/US20040101533A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040101533A1 (en) | 2004-05-27 |
DE10059630A1 (en) | 2002-06-06 |
WO2002043757A3 (en) | 2002-10-17 |
WO2002043757A2 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001227837A1 (en) | Novel treatment for eye disease | |
AU2001233299A1 (en) | Methods for treating alzheimer's disease | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
IL172695A0 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
HK1037861A1 (en) | Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention | |
AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
AU2001275848A1 (en) | Fabric treatment composition | |
AU6246199A (en) | Human interleukin-b50, therapeutic uses | |
EP1440691A3 (en) | Treatment of neurotic disorders | |
AU2002233220A1 (en) | Medicament for preventing or treating tumors caused by human papilloma virus type 18 | |
AU5215300A (en) | Dental treatment area | |
AU2001274877A1 (en) | Pest treatment composition | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU2002215187A1 (en) | S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease | |
IL142581A (en) | Medicament for treating heart disease | |
ZA200110244B (en) | Novel xanthone compounds, their preparation and use as medicament. | |
PL345068A1 (en) | Novel compounds derived from α-d-xylose, preparation method and therapeutic use | |
AU2002331972A1 (en) | 3,4-methylenedioxy-substituted chalcones as therapeutic agents | |
ITMI20001848A0 (en) | DRUGS FOR INCONTINENCE. | |
AU1972200A (en) | Treatment for fabrics | |
AU4225500A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU2136500A (en) | Preparation for dental treatment | |
GB2345857B (en) | Scissors-clip diathermy (SCD) | |
AU5416500A (en) | Pharmaceutical composition for the treatment of calcification |